Guldberg et al. [22] reported favorable outcomes in the intervention group for redeemed recommended prescriptions during follow-up for oral antidiabetic treatment (treatment difference (TD) 20.9%, 95% CIs: 7.9 to 34.8), insulin treatment (TD 21.4%, 95% CIs: 9.9 to 32.8), lipid-lowering medication (TD 19.7%, 95% CIs: 6.1 to 33.2), and blood pressure medication (TD 11.3%, 95% Cis: 1.4 to 21.2) in patients with T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.